331 related articles for article (PubMed ID: 29984646)
21. In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit.
Noshi T; Kitano M; Taniguchi K; Yamamoto A; Omoto S; Baba K; Hashimoto T; Ishida K; Kushima Y; Hattori K; Kawai M; Yoshida R; Kobayashi M; Yoshinaga T; Sato A; Okamatsu M; Sakoda Y; Kida H; Shishido T; Naito A
Antiviral Res; 2018 Dec; 160():109-117. PubMed ID: 30316915
[TBL] [Abstract][Full Text] [Related]
22. Functional domains of the influenza A virus PB2 protein: identification of NP- and PB1-binding sites.
Poole E; Elton D; Medcalf L; Digard P
Virology; 2004 Mar; 321(1):120-33. PubMed ID: 15033571
[TBL] [Abstract][Full Text] [Related]
23. Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.
Giannecchini S; Wise HM; Digard P; Clausi V; Del Poggetto E; Vesco L; Puzelli S; Donatelli I; Azzi A
Antiviral Res; 2011 Oct; 92(1):64-72. PubMed ID: 21741410
[TBL] [Abstract][Full Text] [Related]
24. Functional analysis of PA binding by influenza a virus PB1: effects on polymerase activity and viral infectivity.
Perez DR; Donis RO
J Virol; 2001 Sep; 75(17):8127-36. PubMed ID: 11483758
[TBL] [Abstract][Full Text] [Related]
25. Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses.
Muratore G; Mercorelli B; Goracci L; Cruciani G; Digard P; Palù G; Loregian A
Antimicrob Agents Chemother; 2012 Nov; 56(11):6009-13. PubMed ID: 22908168
[TBL] [Abstract][Full Text] [Related]
26. Hsp90 inhibitors reduce influenza virus replication in cell culture.
Chase G; Deng T; Fodor E; Leung BW; Mayer D; Schwemmle M; Brownlee G
Virology; 2008 Aug; 377(2):431-9. PubMed ID: 18570972
[TBL] [Abstract][Full Text] [Related]
27. Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction.
Watanabe K; Ishikawa T; Otaki H; Mizuta S; Hamada T; Nakagaki T; Ishibashi D; Urata S; Yasuda J; Tanaka Y; Nishida N
Sci Rep; 2017 Aug; 7(1):9500. PubMed ID: 28842649
[TBL] [Abstract][Full Text] [Related]
28. Small RNAs targeting the 5' end of the viral polymerase gene segments specifically interfere with influenza type A virus replication.
Martelli F; Salata C; Calistri A; Parolin C; Azzi A; Palù G; Giannecchini S
J Biotechnol; 2015 Sep; 210():85-90. PubMed ID: 26091771
[TBL] [Abstract][Full Text] [Related]
29. Influenza A virus RNA polymerase subunit PB2 is the endonuclease which cleaves host cell mRNA and functions only as the trimeric enzyme.
Shi L; Summers DF; Peng Q; Galarz JM
Virology; 1995 Apr; 208(1):38-47. PubMed ID: 11831724
[TBL] [Abstract][Full Text] [Related]
30. High-throughput docking for the identification of new influenza A virus polymerase inhibitors targeting the PA-PB1 protein-protein interaction.
Tintori C; Laurenzana I; Fallacara AL; Kessler U; Pilger B; Stergiou L; Botta M
Bioorg Med Chem Lett; 2014 Jan; 24(1):280-2. PubMed ID: 24314669
[TBL] [Abstract][Full Text] [Related]
31. Functional Genomics Reveals Linkers Critical for Influenza Virus Polymerase.
Wang L; Wu A; Wang YE; Quanquin N; Li C; Wang J; Chen HW; Liu S; Liu P; Zhang H; Qin FX; Jiang T; Cheng G
J Virol; 2015 Dec; 90(6):2938-47. PubMed ID: 26719244
[TBL] [Abstract][Full Text] [Related]
32. Targeting of the influenza A virus polymerase PB1-PB2 interface indicates strain-specific assembly differences.
Reuther P; Mänz B; Brunotte L; Schwemmle M; Wunderlich K
J Virol; 2011 Dec; 85(24):13298-309. PubMed ID: 21957294
[TBL] [Abstract][Full Text] [Related]
33. The Surface-Exposed PA
Nilsson-Payant BE; Sharps J; Hengrung N; Fodor E
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875249
[TBL] [Abstract][Full Text] [Related]
34. The structural basis for an essential subunit interaction in influenza virus RNA polymerase.
Obayashi E; Yoshida H; Kawai F; Shibayama N; Kawaguchi A; Nagata K; Tame JR; Park SY
Nature; 2008 Aug; 454(7208):1127-31. PubMed ID: 18660801
[TBL] [Abstract][Full Text] [Related]
35. Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.
Wunderlich K; Mayer D; Ranadheera C; Holler AS; Mänz B; Martin A; Chase G; Tegge W; Frank R; Kessler U; Schwemmle M
PLoS One; 2009 Oct; 4(10):e7517. PubMed ID: 19841738
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions.
Massari S; Desantis J; Nizi MG; Cecchetti V; Tabarrini O
ACS Infect Dis; 2021 Jun; 7(6):1332-1350. PubMed ID: 33044059
[TBL] [Abstract][Full Text] [Related]
37. A novel function of the N-terminal domain of PA in assembly of influenza A virus RNA polymerase.
Suzuki T; Ainai A; Nagata N; Sata T; Sawa H; Hasegawa H
Biochem Biophys Res Commun; 2011 Nov; 414(4):719-26. PubMed ID: 22001919
[TBL] [Abstract][Full Text] [Related]
38. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
[TBL] [Abstract][Full Text] [Related]
39. A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase.
Yuan S; Chu H; Singh K; Zhao H; Zhang K; Kao RY; Chow BK; Zhou J; Zheng BJ
Sci Rep; 2016 Mar; 6():22880. PubMed ID: 26956222
[TBL] [Abstract][Full Text] [Related]
40. Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains.
Shin WJ; Seong BL
Expert Opin Drug Discov; 2019 Feb; 14(2):153-168. PubMed ID: 30585088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
